Brokerages Set GE HealthCare Technologies Inc. (NASDAQ:GEHC) Price Target at $98.75

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have been given a consensus recommendation of “Moderate Buy” by the thirteen research firms that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $98.75.

Several equities research analysts recently commented on GEHC shares. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price target for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company raised their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research note on Friday, February 14th. The Goldman Sachs Group raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and boosted their price target for the company from $85.00 to $100.00 in a research report on Tuesday, March 11th. Finally, Citigroup raised their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th.

GE HealthCare Technologies Trading Up 0.9 %

Shares of GEHC opened at $82.46 on Wednesday. The firm’s fifty day moving average is $86.91 and its two-hundred day moving average is $85.96. The stock has a market cap of $37.71 billion, a PE ratio of 19.04, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. GE HealthCare Technologies has a 52-week low of $74.51 and a 52-week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. Research analysts forecast that GE HealthCare Technologies will post 4.68 earnings per share for the current fiscal year.

Hedge Funds Weigh In On GE HealthCare Technologies

Institutional investors have recently bought and sold shares of the company. Cherry Creek Investment Advisors Inc. lifted its position in shares of GE HealthCare Technologies by 0.3% during the fourth quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company’s stock worth $2,920,000 after purchasing an additional 114 shares in the last quarter. Independence Bank of Kentucky lifted its holdings in GE HealthCare Technologies by 6.0% during the 4th quarter. Independence Bank of Kentucky now owns 2,018 shares of the company’s stock worth $158,000 after buying an additional 114 shares in the last quarter. Haverford Trust Co boosted its position in GE HealthCare Technologies by 2.4% in the 4th quarter. Haverford Trust Co now owns 4,896 shares of the company’s stock valued at $383,000 after buying an additional 115 shares during the period. Tandem Capital Management Corp ADV grew its stake in shares of GE HealthCare Technologies by 0.4% in the fourth quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company’s stock worth $2,205,000 after acquiring an additional 118 shares in the last quarter. Finally, Arcus Capital Partners LLC increased its position in shares of GE HealthCare Technologies by 3.0% during the fourth quarter. Arcus Capital Partners LLC now owns 4,113 shares of the company’s stock worth $322,000 after acquiring an additional 119 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.